Journal article · 2025 · Open access
Cognition in multiple sclerosis within the modern diagnostic and treatment era
Brain, 149(5), 1732–1749 · Published 25 November 2025 · DOI 10.1093/brain/awaf446
In brief
“Cognition in multiple sclerosis within the modern diagnostic and treatment era” is a 2025 journal article by James F. Sumowski and 10 co-authors, published in Brain. OpenAlex counts 18 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Brain.
- Citations
- 18
- Most cited in
- 2026 (18)
- Field-weighted impact
- 8.83
- References
- 111
- Authors
- 11
Abstract
Slowed information processing speed has long been considered the principal cognitive deficit in multiple sclerosis, with slowed cognitive speed presumed responsible for downstream deficits in other functions, including memory. This speed-centric model was established over three decades ago before disease-modifying therapies were available, and contrasts with our current clinical experience, but nonetheless remains dominant and unquestioned. We re-evaluated this model among current patients with multiple sclerosis diagnosed and cared for within the modern diagnostic and treatment era (2001-25). Within a case-control cohort, persons with early relapsing-remitting disease (≤5.0 years since diagnosis, n = 170) performed worse than neurologically-healthy controls (n = 45) on memory but not cognitive speed, and cognitive speed among patients remained normal and stable over the next 6 years despite subtle memory decline. Relative to four historical studies of early relapsing-remitting disease (diagnosed using older criteria), effect sizes for case-control differences in our cohort were much lower for cognitive speed, but comparable for memory. An independent clinical cohort of 1004 consecutive patients aged 18-65 years with relapse-onset multiple sclerosis completed standard-of-care cognitive screenings between 2018 and 2025. We captured data from three independent periods. During the first period (n = 642), rates of poor performance (≤7.5th percentile) did not differ from normative expectations for cognitive speed (8.4%) or attention (9.0%), but were nonetheless elevated for verbal memory (23.8%) and visuospatial memory (14.8%). Patients during the second (n = 123) and third (n = 239) periods demonstrated memory deficits despite normal cognitive speed on co-normed tasks. Objective cognitive speed among current patients was remarkably similar to healthy normative expectations [z-score: mean (standard deviation), 0.03 (1.14); median (interquartile range), 0.00 (-0.67, 0.67)], and was much better than across several historical comparisons from 20-25 years ago. Self-reported cognitive deficits within the total clinical cohort versus control respondents indicated worst disease-related difficulties in expressive language (e.g. word-finding), followed by working memory and episodic memory, with a small difference in executive/speed that was fully explained by mood in relapsing-remitting disease. Current patient-reported attention/executive deficits were lower than 35 years ago, despite comparable memory difficulties. As an exception, attention/executive and cognitive speed deficits were observed in secondary-progressive disease. The speed-centric model of cognitive dysfunction in multiple sclerosis is inaccurate within the modern diagnostic and treatment era. Memory deficits remain prevalent, and we highlight working memory maintenance as an important target for further investigation. The field requires testable models of memory dysfunction informed by contemporary cognitive neuroscience, with the goal of developing heretofore elusive treatments for memory deficits.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Sumowski, J. F., Levy, S. A., Sand, I. K., Brandstadter, R., Dvorak, E., Anderson, J., Fabian, M. T., Graney, R., LUBLIN, F. D., Miller, A., & Sandry, J. D. (2025). Cognition in multiple sclerosis within the modern diagnostic and treatment era. Brain, 149(5), 1732–1749. https://doi.org/10.1093/brain/awaf446
MLA 9
Sumowski, James F., et al. “Cognition in multiple sclerosis within the modern diagnostic and treatment era.” Brain, vol. 149, no. 5, 2025, pp. 1732–1749. https://doi.org/10.1093/brain/awaf446.
Chicago
Sumowski, James F., Sarah A. Levy, Ilana Katz Sand, Rachel Brandstadter, Emily Dvorak, Jordyn Anderson, Michelle T. Fabian, et al. 2025. “Cognition in multiple sclerosis within the modern diagnostic and treatment era.” Brain 149 (5): 1732–1749. https://doi.org/10.1093/brain/awaf446.
Harvard
Sumowski, J. F. et al. (2025) ‘Cognition in multiple sclerosis within the modern diagnostic and treatment era’, Brain, 149(5), pp. 1732–1749. doi:10.1093/brain/awaf446.
IEEE
J. F. Sumowski et al., “Cognition in multiple sclerosis within the modern diagnostic and treatment era,” Brain, vol. 149, no. 5, pp. 1732–1749, 2025, doi: 10.1093/brain/awaf446.
BibTeX
@article{sumowski2025cognition,
title = {{Cognition in multiple sclerosis within the modern diagnostic and treatment era}},
author = {Sumowski, James F. and Levy, Sarah A. and Sand, Ilana Katz and Brandstadter, Rachel and Dvorak, Emily and Anderson, Jordyn and Fabian, Michelle T. and Graney, Robin and LUBLIN, FRED D. and Miller, Aaron and Sandry, Joshua D.},
journal = {Brain},
year = {2025},
volume = {149},
number = {5},
pages = {1732--1749},
doi = {10.1093/brain/awaf446},
url = {https://doi.org/10.1093/brain/awaf446}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- multiple sclerosis
- cognitive impairment
- processing speed
- memory impairment
- relapsing-remitting multiple sclerosis
- disease-modifying therapy
- cognitive screening
- verbal memory
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Sumowski, J. F., Levy, S. A., Sand, I. K., Brandstadter, R., Dvorak, E., Anderson, J., Fabian, M. T., Graney, R., LUBLIN, F. D., Miller, A., & Sandry, J. D. (2025). Cognition in multiple sclerosis within the modern diagnostic and treatment era. Brain, 149(5), 1732–1749. https://doi.org/10.1093/brain/awaf446
How many times has this paper been cited?
18 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Brain: sign in and open the PDF from this page.
Who wrote this paper?
James F. Sumowski, Sarah A. Levy, Ilana Katz Sand, Rachel Brandstadter, Emily Dvorak, Jordyn Anderson, Michelle T. Fabian, Robin Graney, FRED D. LUBLIN, Aaron Miller, Joshua D. Sandry.
What is the DOI of this paper?
10.1093/brain/awaf446, permanently at https://doi.org/10.1093/brain/awaf446. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.